Meanwhile, a clinical trial in the antitumor activity of programmed cell death ligand 1/programmed cell death 1(PD-L1/PD-1) signaling blocking was confirmed useful in multiple types of cancers, including advanced melanoma22. Here, CD274 is linked to cancer.